ACTA1 and Bloom syndrome: To investigate whether the therapeutic efficacy of NFE in the BLM-induced model was due to the reduction in the TGF-β/Smad pathway signaling in rats, we investigated the effect of NFE on the expression of TGF-β1, Smad3/4/7, and α-SMA.